Minami, Noriaki
Hong, Donghyun
Taglang, Celine
Batsios, Georgios
Gillespie, Anne Marie
Viswanath, Pavithra
Stevers, Nicholas
Barger, Carter J.
Costello, Joseph F.
Ronen, Sabrina M.
Funding for this research was provided by:
National Cancer Institute (F31CA254067)
National Institutes of Health (R01CA172845)
University of California, San Francisco (LOGLIO collective)
Article History
Received: 19 January 2023
Accepted: 28 March 2023
First Online: 30 March 2023
Competing interests
: J. Costello is a co-founder of Telo Therapeutics Inc. and has an ownership interest. All other authors have no potential conflict of interest.